FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OLYMPIA PHARMACY | 017674368 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | .29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-13 | |||
| OSRX, Inc. | 83826-9011 | 83826-9011-3 | Atropine Sulfate Monohydrate | Atropine Sulfate Monohydrate 0.025% | .25 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9010 | 83826-9010-3 | Atropine Sulfate Monohydrate | Atropine Sulfate Monohydrate 0.01% | .1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9012 | 83826-9012-3 | Atropine Sulfate Monohydrate | Atropine Sulfate Monohydrate 0.05% | .5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9030 | 83826-9030-5 | Bimatoprost, Brimonidine Tartrate, Dorzolamide | Bimatoprost 0.01%, Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9066 | 83826-9066-5 | Brimonidine Tartrate, Dorzolamide | Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9059 | 83826-9059-2 | Brimonidine Tartrate, Dorzolamide | Brimonidine Tartrate 0.1%, Dorzolamide 2% | 20 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9076 | 83826-9076-5 | Cyclopentolate hcl, Tropicamide, Phenylephrine HCl | Cyclopentolate hcl 1%,Tropicamide 1%, Phenylephrine HCl 2.5% | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9004 | 83826-9004-1 | Dexamethasone phosphate, Moxiflocacin HCl | Dexamethasone phosphate 0.1%, Moxiflocacin HCl 0.5% | 5 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9080 | 83826-9080-1 | Moxiflocacin HCl | Moxiflocacin HCl 0.1% | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9034 | 83826-9034-5 | Moxifloxacin, Bromfenac | Moxifloxacin 0.5%, Bromfenac 0.075% | 10 mg/1 mL; 75 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9055 | 83826-9055-5 | Prednisolone Phosphate, Bromfenac | Prednisolone Phosphate 1%, Bromfenac 0.075% | 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9033 | 83826-9033-5 | Prednisolone Phosphate, Moxifloxacin | Prednisolone Phosphate 1%, Moxifloxacin 0.5% | 10 mg/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9017 | 83826-9017-8 | Prednisolone Phosphate, Moxifloxacin HCl, Ketorolac Tromethamine | Prednisolone Phosphate 1%, Moxifloxacin HCl 0.5%, Ketorolac Tromethamine 0.5% | 5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9016 | 83826-9016-8 | Prednisolone Phosphate, Moxifloxacin, Bromfenac | Prednisolone Phosphate 1%, Moxifloxacin 0.5%, Bromfenac 0.075% | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| OSRX, Inc. | 83826-9014 | 83826-9014-5 | Prednisolone Phosphate, Moxifloxacin, Bromfenac | Prednisolone Phosphate 1%, Moxifloxacin 0.5%, Bromfenac 0.075% | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-2 | valid | 2026-09-18 |